60
Views
16
CrossRef citations to date
0
Altmetric
Review

Current pharmacotherapy of allergic bronchopulmonary aspergillosis

&
Pages 1065-1071 | Published online: 24 Feb 2005

Bibliography

  • STEVENS DA, KAN VL, JUDSON MA et al.: Practice guidelines for disease caused by Aspergillus. OM. Infect. Dis. (2000) 30:696–709.
  • ••A recent consensus group publicationaddressing treatment.
  • HINSON KF, MOON AJ, PLUMMER NS: Bronchopulmonary aspergillosis. Thorax (1952) 7:317–333.
  • PATTERSON R, GREENBERGER PA, ROBERTS ML et al.: Allergic bronchopulmonary aspergillosis. Oceanside Publications, Providence, RI (1995).
  • VARKEY B: Allergic bronchopulmonary aspergillosis: clinical perspectives. Immuriol All. Chit. North Am. (1998) 18:480–501.
  • ROSENBERG M, PATTERSON R, MINTZER R, COOPER BJ, ROBERTS M, HARRIS KE: Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann. Intern. Med. (1997) 86:405–414.
  • GELLER DE, KAPLOWITZ H, LIGHT MJ, COLIN AA: Allergic bronchopulmonary aspergillosis in cystic fibrosis. Chest (1999) 116:639–646.
  • ELLIOT MW, TAYLOR JN: Allergic bronchopulmonary aspergillosis. OM. Exp. Allergy (1997) 27\(Supp1.1):55–59.
  • MALO JL, HAWINS R, PEPYS J: Studies in chronic allergic bronchopulmonary aspergillosis: clinical and physiological findings. Thorax (1977) 32:254–261.
  • BASICH JE, GRAVES TS, NASIR BAZ M et al.: Allergic bronchopulmonary aspergillosis in corticosteroid-dependent asthmatics. J Allergy Clin. Immuriol (1981) 68:98–102.
  • MROUCH S, SPOCK A: Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Chest (1994) 105:32–36.
  • NEPOMUCENO IB, ESRIG S, MOSS RB: Allergic bronchopulmonary aspergillosis in cystic fibrosis. Chest (1999) 115:364–370.
  • McCARTHY DS, SIMON G, HARGREAVE FE: The radiological appearances in allergic bronchopulmonary aspergillosis. Clin. Radial. (1970) 21:366–375.
  • WARD S, HEYNEMAN L, LEE MJ et al:Accuracy of CT in the diagnosis of allergic bronchopulmonary aspergillosis in asthmatic patients. AR (1999) 173:937–942.
  • MITCHELL TAM, HAMILOS DL, LYNCH DA, NEWELL JD: Distribution and severity of bronchiectasis in allergic bronchopulmonary aspergillosis. j Asthma (2000) 37:65–72.
  • SCHUYLER MR: Allergic bronchopulmonary aspergillosis. Chit. Chest Med. (1983) 4:15–22.
  • PATTERSON R, GREENBERGER PA, HARRIS KE: Allergic bronchopulmonary aspergillosis (editorial). Chest (2000) 118:7–8.
  • PATTERSON R, GREENBERGER PA, HALWIG JM, LIOTTA JL, ROBERTS M: Allergic bronchopulmonary aspergillosis: natural history and classification of early disease by serologic and roentgenographic studies. Arch. Intern. Med (1986) 146:916–918.
  • ••One of many publications by an expertgroup delineating the disease.
  • ROSENBERG M, PATTERSON R, ROBERTS M, WANG J: The assessment of immunologic and clinical changes occurring during corticosteroid therapy for allergic bronchopulmonary aspergillosis. Am. Med. (1978) 64:599–606.
  • •Landmark paper describing the use of steroids acutely.
  • CAPEWELL S, CHAPMAN BJ, ALEXANDER F, GREENING AP CROMPTON GK: Corticosteroid treatment and prognosis in pulmonary eosinophilia. Thorax (1989) 44:925–929.
  • SAFIRSTEIN BH, D'SOUSA MF, SIMON G, TAI EHC, PEPYS J: Five year follow-up of allergic bronchopulmonary aspergillosis. Am. Rev Respir: Dis. (1973) 108:450–459.
  • •Landmark paper describing chronic treatment with steroids.
  • MIDDLETON WG, PATERSON IC, GRANT IWB, DOUGLAS AC: Asthmatic pulmonary eosinophilia: a review of 65 cases. Br. J. Dis. Chest (1977) 71:115–122.
  • National Asthma Education and Prevention Program. Expert panel report 2: Guidelines for the diagnosis and management of asthma; clinical practice guidelines, component 3. Bethesda, MD. National Institutes of Health, April (1997); Publication No. 97–405.
  • RILEY DJ, MACKENZIE JR, UHLMAN WE, EDELMAN NH: Allergic bronchopulmonary aspergillosis: evidence of limited tissue invasion. Am. Rev Respir Dis. (1975) 111:232–236.
  • STEVENS DA, SCHWARTZ HJ, LEE JY etal.: A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl. j Med. (2000) 342:756–762.
  • ••First controlled trial in ABPA and provedefficacy of an antifungal.
  • LEON EE, CRAIG TJ. Antifungals in the treatment of allergic bronchopulmonary aspergillosis. Ann. Allergy Asthma Immuriol (1999) 82:511–517.
  • STEVENS DA, BENNETT JE: Antifungal drugs. In: Principles and Practice of Infectious Disease(Edition 5). Mandell GL, Bennett JE, Dolin R (Eds.), Churchill and Livingstone Publishers (2000):Chapter 35.
  • STEVENS DA: Itraconazole in cyclodextrin solution. Pharmacotherapy (1999) 19:603–611.
  • STEVENS DA: New azoles. 40th Interscience Conference On Antimicrobial Agents and Chemotherapy Toronto, Canada (2000) 1122.
  • STEVENS DA: Combination immunotherapy and antifungal chemotherapy. OM Infect. Dis. (1998) 26:1266–1269.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.